BridgeBio Oncology Awards 32,675 Stock Options to New Employee

Key Highlights

• BridgeBio Oncology awarded inducement grants on May 10, 2026, to one new employee.
• The employee received non-qualified stock options to purchase 32,675 shares of common stock.
• The exercise price for the options is $7.66 per share, based on the closing price on the grant date.
• The awards will vest 1/4 on the first anniversary of the employee's start date, then in 36 equal monthly installments.
• The grants were made under BBOT’s 2025 Inducement Plan, adopted in October 2025.
• The compensation committee approved the awards as a material inducement for employment.